48Hour Discovery
PrivateLast Round
Grant
Jun 24, 2025
Total Funding Raised
$3.41M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
48Hour Discovery operates in Healthcare & Life Sciences and is based in Edmonton. Its latest recorded funding round was a Grant round in June 2025.
48Hour Discovery is a biotechnology company that provides a peptide-based drug discovery platform to accelerate the identification and optimization of therapeutic leads.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
48Hour Discovery Comparables
Compare 48Hour Discovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orbit Discovery | 84% | |
| 20n Bio | 83% | |
| ProteinQure | 81% |
For institutional investors. Book with your work email.
48Hour Discovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 24, 2025 | ||||
| Debt | Jun 24, 2024 | ||||
| Grant | May 8, 2024 | ||||
| Grant | Jan 23, 2024 | ||||
| Grant | Jan 1, 2023 | ||||
Grant | Mar 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
48Hour Discovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Glycomics Network | Grant |
| Consortium Québécois sur la découverte du médicament | Grant |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| National Research Council Canada | Grant |
| Alberta Cancer Foundation | Grant |
| Alberta Innovates | Grant |
| Edmonton | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 16, 2.4x the trailing average.
- Jul 20, 2026
Open roles increased to 16, 123% of headcount.
For institutional investors. Book with your work email.
48Hour Discovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 48Hour Discovery's valuation, stock price, and market status.
Is 48Hour Discovery a public or private company?
48Hour Discovery is a private company.
What is the current stock price of 48Hour Discovery?
48Hour Discovery is a private company, so its shares have no public market price. Caplight tracks 48Hour Discovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 48Hour Discovery worth (valuation)?
Valuation information for 48Hour Discovery is not publicly available.
Can I buy 48Hour Discovery stock?
48Hour Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 48Hour Discovery's last funding round?
48Hour Discovery's most recent funding round was Grant on June 24, 2025.
Who are the main investors in 48Hour Discovery?
Key investors in 48Hour Discovery include Canadian Glycomics Network, Consortium Québécois sur la découverte du médicament, National Research Council Canada Industrial Research Assistance Program, National Research Council Canada, Alberta Cancer Foundation.
Will 48Hour Discovery IPO soon?
No public IPO plans have been announced for 48Hour Discovery.
How can I track 48Hour Discovery secondary market activity?
Caplight tracks bids, offers, and trades in 48Hour Discovery's shares on secondary markets.